Notes
vascular endothelial growth factor
Reference
Yin G, et al. Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials. Journal of Chemotherapy : 1-14, 6 Jul 2021. Available from: URL: http://doi.org/10.1080/1120009X.2021.1947022
Rights and permissions
About this article
Cite this article
Anti-VEGF monoclonal antibodies: risk of hypertension in cancer patients. Reactions Weekly 1864, 6 (2021). https://doi.org/10.1007/s40278-021-98936-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-98936-6